Literature DB >> 1836286

Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood.

M A Bean1, R Storb, T Graham, R Raff, G E Sale, F Schuening, F R Appelbaum.   

Abstract

Dogs given total-body irradiation and marrow transplants from DLA-identical littermates exhibit prompt and sustained hematopoietic engraftment. However, animals given three preceding blood transfusions from the marrow donor before transplant become sensitized and reject the marrow graft. Rejection is due to exposure to polymorphic minor non-DLA histocompatibility antigens expressed on blood mononuclear cells. We sought to determine whether heat treatment would prevent blood from sensitizing recipients in this model since heating blood to 45 degrees C for 45 min abrogates the ability of blood mononuclear cells to stimulate in mixed lymphocyte culture. Three of 4 evaluable dogs given heat-treated blood before transplant rejected their marrow grafts. To prevent possible reexpression/reacquisition of mononuclear cell functional activity in vivo after transfusion, subsequent dogs were given heated blood that was additionally exposed to 2000 cGy gamma irradiation. Eight of 10 evaluable dogs given blood treated in this fashion engrafted. Unexpectedly, 9 out of 10 evaluable dogs transfused with blood treated only with gamma irradiation also engrafted. These results demonstrate that treatment of blood with gamma irradiation alone or in combination with heat prevents transfusion-induced sensitization to minor histocompatibility antigens. Results from this canine model suggest that blood products be gamma irradiated before transfusion in patients who are transplant candidates in order to prevent sensitization to minor histocompatibility antigens and reduce the risk of marrow graft rejection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836286     DOI: 10.1097/00007890-199112000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Success of allogeneic marrow transplantation for children with severe aplastic anaemia.

Authors:  Lauri M Burroughs; Ann E Woolfrey; Barry E Storer; H Joachim Deeg; Mary E D Flowers; Paul J Martin; Paul A Carpenter; Kris Doney; Frederick R Appelbaum; Jean E Sanders; Rainer Storb
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

2.  Mixed chimerism renders residual host dendritic cells incapable of alloimmunization of the marrow donor in the canine model of allogeneic marrow transplantation.

Authors:  Steven L Rosinski; Scott S Graves; Deborah A Higginbotham; Rainer Storb
Journal:  Chimerism       Date:  2015-10-02

Review 3.  Stem cell transplantation for aplastic anemia.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

Review 4.  Graft failure after allogeneic hematopoietic cell transplantation.

Authors:  Jonas Mattsson; Olle Ringdén; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

5.  Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.

Authors:  M Lupu; R Storb
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613

Review 6.  Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.

Authors:  George E Georges; Kris Doney; Rainer Storb
Journal:  Blood Adv       Date:  2018-08-14

7.  Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization".

Authors:  Aya Nakaya; Huiying Qiu; Erlinda B Santos; Donald K Hamlin; D Scott Wilbur; Rainer Storb; Brenda M Sandmaier
Journal:  Transplant Cell Ther       Date:  2021-02-25

8.  Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Authors:  S Gallo; A E Woolfrey; L M Burroughs; B E Storer; M E D Flowers; P Hari; M A Pulsipher; S Heimfeld; H-P Kiem; B M Sandmaier; R Storb
Journal:  Bone Marrow Transplant       Date:  2016-08-01       Impact factor: 5.483

9.  Autologous peripheral blood hematopoietic cell transplantation in dogs with T-cell lymphoma.

Authors:  E E Warry; J L Willcox; S E Suter
Journal:  J Vet Intern Med       Date:  2014-01-27       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.